Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7876615rdf:typepubmed:Citationlld:pubmed
pubmed-article:7876615lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:7876615lifeskim:mentionsumls-concept:C0001675lld:lifeskim
pubmed-article:7876615lifeskim:mentionsumls-concept:C0682125lld:lifeskim
pubmed-article:7876615lifeskim:mentionsumls-concept:C0795623lld:lifeskim
pubmed-article:7876615lifeskim:mentionsumls-concept:C0302891lld:lifeskim
pubmed-article:7876615pubmed:issue3lld:pubmed
pubmed-article:7876615pubmed:dateCreated1995-4-6lld:pubmed
pubmed-article:7876615pubmed:abstractTextThe response to an inactivated hepatitis A vaccine was assessed in 307 persons: 163 Alaska Native children, ages 3-6 years, and 144 Native (84) and non-Native (60) adults. All adults received the same vaccine schedule (0, 1, and 12 months), whereas children were randomized to receive three different schedules (0, 1, and 6; 0, 1, and 2; or 0, 1, and 12 months). After one dose, 141 (96%) of 147 children and 129 (90%) of 143 adults responded with levels of antibody to hepatitis A virus > 20 mIU/mL. After three doses, all participants responded. The geometric mean titer (GMT) 1 month after the third dose was significantly higher in children who received the third dose 12 months after the first dose rather than 2 months after the first dose. While there were differences in the GMT of some blood samples by age, sex, and ethnicity, all participants responded to the vaccine.lld:pubmed
pubmed-article:7876615pubmed:languageenglld:pubmed
pubmed-article:7876615pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7876615pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7876615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7876615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7876615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7876615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7876615pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7876615pubmed:statusMEDLINElld:pubmed
pubmed-article:7876615pubmed:monthMarlld:pubmed
pubmed-article:7876615pubmed:issn0022-1899lld:pubmed
pubmed-article:7876615pubmed:authorpubmed-author:KrauseDDlld:pubmed
pubmed-article:7876615pubmed:authorpubmed-author:WilliamsJJlld:pubmed
pubmed-article:7876615pubmed:authorpubmed-author:KennedyMMlld:pubmed
pubmed-article:7876615pubmed:authorpubmed-author:WainwrightRRlld:pubmed
pubmed-article:7876615pubmed:authorpubmed-author:McMahonB JBJlld:pubmed
pubmed-article:7876615pubmed:authorpubmed-author:BulkowLLlld:pubmed
pubmed-article:7876615pubmed:authorpubmed-author:SnowballMMlld:pubmed
pubmed-article:7876615pubmed:issnTypePrintlld:pubmed
pubmed-article:7876615pubmed:volume171lld:pubmed
pubmed-article:7876615pubmed:ownerNLMlld:pubmed
pubmed-article:7876615pubmed:authorsCompleteYlld:pubmed
pubmed-article:7876615pubmed:pagination676-9lld:pubmed
pubmed-article:7876615pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7876615pubmed:meshHeadingpubmed-meshheading:7876615-...lld:pubmed
pubmed-article:7876615pubmed:meshHeadingpubmed-meshheading:7876615-...lld:pubmed
pubmed-article:7876615pubmed:meshHeadingpubmed-meshheading:7876615-...lld:pubmed
pubmed-article:7876615pubmed:meshHeadingpubmed-meshheading:7876615-...lld:pubmed
pubmed-article:7876615pubmed:meshHeadingpubmed-meshheading:7876615-...lld:pubmed
pubmed-article:7876615pubmed:meshHeadingpubmed-meshheading:7876615-...lld:pubmed
pubmed-article:7876615pubmed:meshHeadingpubmed-meshheading:7876615-...lld:pubmed
pubmed-article:7876615pubmed:meshHeadingpubmed-meshheading:7876615-...lld:pubmed
pubmed-article:7876615pubmed:meshHeadingpubmed-meshheading:7876615-...lld:pubmed
pubmed-article:7876615pubmed:meshHeadingpubmed-meshheading:7876615-...lld:pubmed
pubmed-article:7876615pubmed:meshHeadingpubmed-meshheading:7876615-...lld:pubmed
pubmed-article:7876615pubmed:meshHeadingpubmed-meshheading:7876615-...lld:pubmed
pubmed-article:7876615pubmed:meshHeadingpubmed-meshheading:7876615-...lld:pubmed
pubmed-article:7876615pubmed:meshHeadingpubmed-meshheading:7876615-...lld:pubmed
pubmed-article:7876615pubmed:year1995lld:pubmed
pubmed-article:7876615pubmed:articleTitleImmunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults.lld:pubmed
pubmed-article:7876615pubmed:affiliationAlaska Native Medical Center, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage 99501.lld:pubmed
pubmed-article:7876615pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7876615pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7876615pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:7876615pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed